(1)
Mofid, B.; Razzaghdoust, A.; Ghajari, M.; Basiri, A.; Fattahi, M.-R.; Houshyari, M.; Jafari, A.; Taghizadeh-Hesary, F. The Oncological Outcomes of Neoadjuvant Gemcitabine Plus Carboplatin Versus Gemcitabine Plus Cisplatin in Locally Advanced Bladder Cancer: A Retrospective Analysis: Neoadjuvant Carboplatin in Locally Advanced Bladder Cancer. Urol J 2022, 19, 6841.